Ivermection-loaded solid lipid nanoparticles: preparation, characterisation, stability and transdermal behaviour

References

• Romani L, Steer AC, Whitfeld MJ, et al. Prevalence of scabies and impetigo worldwide: a systematic review. Lancet Infect Dis. 2015a;15:960–967.
   PubMed Web of Science ®Google Scholar
• Currie BJ. Scabies and global control of neglected tropical diseases. N Engl J Med. 2015;373:2371–2372.
   PubMed Web of Science ®Google Scholar
• Romani L, Whitfeld MJ, Koroivueta J, et al. Mass drug administration for scabies control in a population with endemic disease. N Engl J Med. 2015b;373:2305–2313.
   PubMed Web of Science ®Google Scholar
• Moreno L, Dominguez P, Farias C, et al. Ivermectin pharmacokinetics, metabolism, and tissue/egg residue profiles in laying hens. J Agric Food Chem. 2015;63:10327–10332.
   PubMed Web of Science ®Google Scholar
• Goldust M, Rezaee E, Raghifar R, et al. Treatment of scabies: the topical ivermectin vs. permethrin 2.5% cream. Ann Parasitol. 2013;59:79–84.
   PubMedGoogle Scholar
• Panahi Y, Poursaleh Z, Goldust M. The efficacy of topical and oral ivermectin in the treatment of human scabies. Ann Parasitol. 2015;61:11–16.
   PubMedGoogle Scholar
• Steer AC, Kearns T, Andrews RM, McCarthy JS, Carapetis JR, Currie BJ. Ivermectin worthy of further investigation. Bull World Health Organ. 2009;87:A–B.
   PubMedGoogle Scholar
• Nuruzzaman M, Rahman MM, Liu Y, et al. Nanoencapsulation, nano-guard for pesticides: a new window for safe application. J Agric Food Chem. 2016;64:1447–1483.
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366:170–184.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165–196.
   PubMed Web of Science ®Google Scholar
• Lauterbach A, Muller-Goymann CC. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route. Eur J Pharm Biopharm. 2015;97:152–163.
   PubMed Web of Science ®Google Scholar
• Kakadia PG, Conway BR. Lipid nanoparticles for dermal drug delivery. Curr Pharm Des. 2015;21:2823–2829.
   PubMed Web of Science ®Google Scholar
• Jenning V, Gysler A, Schäfer-Korting M, et al. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm. 2000;49:211–218.
   PubMed Web of Science ®Google Scholar
• Liu J, Hu W, Chen H, et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 2007;328:191–195.
   PubMed Web of Science ®Google Scholar
• Lv Q, Yu A, Xi Y, et al. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm. 2009;372:191–198.
   PubMed Web of Science ®Google Scholar
• Gupta M, Vyas SP. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids. 2012;165:454–461.
   PubMed Web of Science ®Google Scholar
• Pradhan M, Singh D, Singh MR. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis. Chem Phys Lipids. 2015;186:9–16.
   PubMed Web of Science ®Google Scholar
• Zhu W, Yu A, Wang W, et al. Formulation design of microemulsion for dermal delivery of penciclovir. Int J Pharm. 2008;360:184–190.
   PubMed Web of Science ®Google Scholar
• Mei Z, Chen H, Weng T, et al. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm. 2003;56:189–196.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Shukla D, Mishra B, et al. Lipid–an emerging platform for oral delivery of drugs with poor bioavailability. Eur J Pharm Biopharm. 2009;73:1–15.
   PubMed Web of Science ®Google Scholar
• Kohli AK, Alpar HO. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Int J Pharm. 2004;275:13–17.
   PubMed Web of Science ®Google Scholar
• Mitri K, Shegokar R, Gohla S, et al. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. Int J Pharm. 2011;414:267–275.
   PubMed Web of Science ®Google Scholar
• Kalhapure RS, Sonawane SJ, Sikwal DR, et al. Solid lipid nanoparticles of clotrimazole silver complex: an efficient nano antibacterial against Staphylococcus aureus and MRSA. Colloids Surf B Biointerfaces. 2015;136:651–658.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mira E, Egea MA, Garcia ML, et al. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids Surf B Biointerfaces. 2010;81:412–421.
   PubMed Web of Science ®Google Scholar
• Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery dystems – a review (part 1). Trop J Pharm Res. 2013;12:265–273.
   Web of Science ®Google Scholar
• Gomes MJ, Martins S, Ferreira D, et al. Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies. Int J Nanomedicine 2013;9:1231–1242.
   Web of Science ®Google Scholar
• Ghanbarzadeh S, Hariri R, Kouhsoltani M, et al. Enhanced stability and dermal delivery of hydroquinone using solid lipid nanoparticles. Colloids Surf B Biointerfaces. 2015;136:1004–1010.
   PubMed Web of Science ®Google Scholar
• Nnamani PO, Hansen S, Windbergs M, et al. Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application. Int J Pharm. 2014;477:208–217.
   PubMed Web of Science ®Google Scholar
• Jose S, Anju SS, Cinu TA, et al. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Int J Pharm. 2014;474:6–13.
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54 Suppl 1:S131–S155.
   PubMed Web of Science ®Google Scholar
• Sun J, Bi C, Chan HM, et al. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Colloids Surf B Biointerfaces. 2013;111:367–375.
   PubMed Web of Science ®Google Scholar
• zur Mühlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery–drug release and release mechanism. Eur J Pharm Biopharm. 1998;45:149–155.
   PubMed Web of Science ®Google Scholar
• Gokhale R, Schmidt C, Alcorn L, et al. Transdermal drug delivery systems of albuterol: in vitro and in vivo studies. J Pharm Sci. 1992;81:996–999.
   PubMed Web of Science ®Google Scholar
• Gönüllü Ü, Üner M, Yener G, et al. Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery. Acta Pharm. 2015;65:1–13.
   PubMed Web of Science ®Google Scholar